Watch AHCO. Know when insiders buy.
One email the day a filing lands. Free.
AHCO
AdaptHealth Corp.
6.49
+0.07 +1.09%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
65
PASS · shorts 65
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $884.9MP/E —DIV YIELD —FCF YIELD 11.04%REV TTM $3.2B +4.2%NET INCOME −$228.2M −383.2%NET DEBT $1.9B52W 5.22 – 13.38SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $740.3M | +12.7% | 14.1% | −$137.8M | −$133.9M | −1012.7% | -0.99 | $145.3M | $166.2M | −$20.9M | Aug 4 |
| Q1 2026 · Mar 31 | $819.8M | +5.4% | 13.6% | $5.5M | −$16M | — | -0.12 | $93.7M | $121.2M | −$27.5M | May 5 |
| Q4 2025 · Dec 31derived | $846.3M | −1.2% | 20.3% | −$73.3M | −$102.8M | −304.5% | -0.73 | $183.2M | $103.9M | $79.3M | Feb 24 |
| Q3 2025 · Sep 30 | $820.3M | +1.8% | 19.7% | $61.7M | $24.5M | +7.2% | 0.16 | $161.1M | $94.2M | $66.8M | Nov 4 |
| Q2 2025 · Jun 30 | $657.1M | −18.5% | 20.7% | $65.7M | $14.7M | −24.5% | 0.10 | $162M | $88.7M | $73.3M | Aug 4 |
| Q1 2025 · Mar 31 | $777.9M | −1.8% | 15.5% | $23.2M | −$7.2M | — | -0.05 | $95.5M | $95.6M | −$58K | May 5 |
| Q4 2024 · Dec 31derived | $856.6M | −0.2% | 22.4% | $97.7M | $50.3M | — | 0.34 | $150.4M | $77.3M | $73.1M | Feb 24 |
| Q3 2024 · Sep 30 | $805.9M | +0.2% | 20.1% | $63.5M | $22.9M | — | 0.15 | $144.4M | $59.6M | $84.8M | Nov 4 |
| Q2 2024 · Jun 30 | $806M | — | 21.0% | $52M | $19.4M | — | 0.13 | $198M | $81.3M | $116.7M | Aug 5 |
| Q1 2024 · Mar 31 | $792.5M | — | 19.9% | $50.5M | −$2.1M | — | -0.02 | $49M | $87.9M | −$38.9M | May 6 |
| Q4 2023 · Dec 31derived | $858.2M | — | 35.5% | −$217.8M | −$254.5M | — | -1.94 | $155.3M | $88.6M | $66.6M | Feb 24 |
| Q3 2023 · Sep 30 | $804M | — | 13.7% | −$461M | −$454.1M | — | -3.43 | $98.8M | $77.1M | $21.7M | Nov 5 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $3.2B | 18.8% | $90.9M | −$70.8M | -2.2% | -0.52 | $601.8M | $382.4M | $219.4M | $0 | — |
| FY2024 · to Dec 31 | $3.3B | 20.9% | $263.7M | $90.4M | 2.8% | 0.61 | $541.8M | $306.1M | $235.8M | $0 | — |
| FY2023 · to Dec 31 | $3.2B | 19.5% | −$598.4M | −$678.9M | -21.2% | -5.31 | $480.7M | $337.5M | $143.2M | $29.3M | — |
| FY2022 · to Dec 31 | $3B | 19.5% | $190.4M | $69.3M | 2.3% | 0.33 | $373.9M | $391.4M | −$17.6M | $14M | — |
| FY2021 · to Dec 31 | $2.5B | 18.2% | $225.6M | $156.2M | 6.4% | 0.67 | $275.7M | $203.3M | $72.4M | $0 | — |
| FY2020 · to Dec 31 | $1.1B | 14.9% | $71.3M | −$161.6M | -15.3% | -3.08 | $195.6M | $39.8M | $155.9M | $0 | — |
Every number comes from AdaptHealth Corp.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.